Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Marrow Transplant Rejection”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Testing effectiveness (Phase 2)Study completedNCT01745731
What this trial is testing

Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration

Who this might be right for
Liver Transplant Rejection
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 13
Not applicableLooking for participantsNCT01163578
What this trial is testing

Biomarkers in Transplant Recipients to Improve Outcomes

Who this might be right for
Solid Organ TransplantationBone Marrow Transplantation
University of Pittsburgh 1,200
Not applicableStudy completedNCT00619528
What this trial is testing

HLA-Identical Sibling Renal Transplant Tolerance

Who this might be right for
ImmunosuppressionKidney TransplantationGraft Rejection
Northwestern University 88
Not applicableStudy completedNCT00658073
What this trial is testing

Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts

Who this might be right for
Renal Transplant Rejection
Fuzhou General Hospital 165
Testing effectiveness (Phase 2)UnknownNCT02057965
What this trial is testing

Mesenchymal Stromal Cell Therapy in Renal Recipients

Who this might be right for
Renal Transplant RejectionFibrosis
Leiden University Medical Center 70
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Study completedNCT00734396
What this trial is testing

Mesenchymal Stem Cells and Subclinical Rejection

Who this might be right for
Organ Transplantation
Leiden University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT00397813
What this trial is testing

Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

Who this might be right for
Atypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Myelomonocytic Leukemiade Novo Myelodysplastic Syndrome+11 more
Fred Hutchinson Cancer Center 77
Not applicableStudy completedNCT02194439
What this trial is testing

Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease

Who this might be right for
Graft-Versus-Host Disease
Indiana University 415
Testing effectiveness (Phase 2)Study completedNCT00079391
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

Who this might be right for
Hematologic MalignanciesBone Marrow Transplant Rejection
National Heart, Lung, and Blood Institute (NHLBI) 50
Testing effectiveness (Phase 2)Ended earlyNCT00005852
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Study completedNCT00063817
What this trial is testing

Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant

Who this might be right for
End-stage Renal DiseaseRenal TransplantationKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 5
Early research (Phase 1)UnknownNCT02260375
What this trial is testing

MSC Therapy in Liver Transplantation

Who this might be right for
Liver Transplant Rejection
Monia Lorini 20
Testing effectiveness (Phase 2)Study completedNCT00801632
What this trial is testing

Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection

Who this might be right for
Kidney TransplantationKidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)Study completedNCT00353860
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances

Who this might be right for
ImmunosuppressionLeukemia
National Heart, Lung, and Blood Institute (NHLBI) 70
Not applicableStudy completedNCT00382486
What this trial is testing

Low Dose Irradiation for Small Bowel Transplant

Who this might be right for
Irreversible Intestinal FailureAllograft Rejection
University of Pittsburgh 100
Testing effectiveness (Phase 2)Study completedNCT00096161
What this trial is testing

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
Fred Hutchinson Cancer Center 36
Testing effectiveness (Phase 2)UnknownNCT02563340
What this trial is testing

Effect of BM-MSCs on Chronic AMR After Kidney Transplantation

Who this might be right for
Kidney Transplantation
First Affiliated Hospital, Sun Yat-Sen University 60
Early research (Phase 1)Study completedNCT02387151
What this trial is testing

Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients

Who this might be right for
RejectionGraft Loss
Leiden University Medical Center 10